Franco Tarro Genta

Cyclophosphamide, Methotrexate, and Fluorouracil Versus Tamoxifen Plus Ovarian Suppression as Adjuvant Treatment of Estrogen Receptor–Positive Pre-/Perimenopausal Breast Cancer Patients: Results of the Italian Breast Cancer Adjuvant Study Group 02 Randomized Trial

Francesco Boccardo, A. Rubagotti, D. Amoroso et al. · Journal of Clinical Oncology · 2000 · 185 citations

Prognostic Relevance of a Non-Invasive Evaluation of Right Ventricular Function and Pulmonary Artery Pressure in Patients with Chronic Heart Failure

Stefano Ghio, Pier Luigi Temporelli, Catherine Klersy et al. · European Journal of Heart Failure · 2013 · 172 citations · Full text

Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma.

Hjg Arts, D Katsaros, Elisabeth G.E. de Vries et al. · PubMed · 1999 · 113 citations

Prognostic Factors, Prognostic Biomarkers, Lung Resistance Protein +15

Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen in node-positive, oestrogen-receptor positive breast cancer patients. An update at 7 years of the 1st GROCTA (breast cancer adjuvant chemo-hormone therapy cooperative group) trial

Francesco Boccardo, A. Rubagotti, D. Amoroso et al. · European Journal of Cancer · 1992 · 58 citations

Endocrine Oncology, Breast Oncology, Oncology +7

Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis

Frank Lloyd Dini, Stefano Ghio, Catherine Klersy et al. · International Journal of Clinical Practice · 2013 · 44 citations